Brief: Scpharmaceuticals Announces Positive Results From The At Home-Hf Phase 2 Pilot Study In Heart Failure

Scpharmaceuticals

12/07/2022 14:24

July 12 (Reuters) - scPharmaceuticals Inc  SCPH.O :
    * SCPHARMACEUTICALS INC. ANNOUNCES POSITIVE RESULTS FROM THE
AT
HOME-HF PHASE 2 PILOT STUDY IN HEART FAILURE
    * SCPHARMACEUTICALS INC - STUDY RESULTS FAVOR FUROSCIX
VERSUS
"TREATMENT AS USUAL" IN COMPOSITE PRIMARY ENDPOINT AND ALL
SECONDARY ENDPOINTS
    * SCPHARMACEUTICALS INC - FUROSCIX DEMONSTRATED AN
ACCEPTABLE
TOLERABILITY PROFILE
    * SCPHARMACEUTICALS INC - COMPANY ON TRACK FOR Q4 2022
COMMERCIAL
LAUNCH OF FUROSCIX, IF APPROVED

Source text for Eikon:  ID:nGNXbK5sBb 
Further company coverage:  SCPH.O 

 ((reuters.briefs@thomsonreuters.com;))